Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

J.P. Morgan analyst Jessica Fye has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Stay Ahead of the ...

The stock market is where investors connect to buy and sell investments — most commonly, stocks, which are shares of ownership in a public company. Many, or all, of the products featured on this ...

U.S. stock indexes were mixed, with the Nasdaq under pressure again as investors keep trimming forecasts for rate cuts. Chips also dip on export curb.

Nvidia, AMD, and Broadcom sold off after the Biden Administration released new AI chip export rules late Friday.

Moderna Inc. (NYSE: MRNA) has revised its sales projections for 2025, lowering expectations due to sluggish demand for its ...

Here’s why it worth staying invested in the U.S. stock market despite the recent rout and higher bond yields, according to ...

Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.

Possible sanction tightening on Russian oil sent crude to its highest close in five months in today's trading. February-dated West Texas Intermediate (WTI) crude added $2.25, or 2.9%, to settle $78.82 ...

Shares in Cambridge biopharma company Arecor Therapeutics hit a 52-week low at 54.75p on Friday before recovering to close at ...

GBP/USD tapped a fresh 14-month low on Thursday as the Pound Sterling rolls over further against the Greenback. Holiday-thinned markets are keeping one foot firmly in the safe haven US Dollar as ...

Constellation Brands shares plunged Friday, after the maker of beer, wine, and spirits cut its guidance as consumers held ...